HRP20120018T1 - Uporaba derivata benzo-kondenziranih heterocikličkih sulfamida kao neurozaštitnih sredstava - Google Patents
Uporaba derivata benzo-kondenziranih heterocikličkih sulfamida kao neurozaštitnih sredstava Download PDFInfo
- Publication number
- HRP20120018T1 HRP20120018T1 HR20120018T HRP20120018T HRP20120018T1 HR P20120018 T1 HRP20120018 T1 HR P20120018T1 HR 20120018 T HR20120018 T HR 20120018T HR P20120018 T HRP20120018 T HR P20120018T HR P20120018 T1 HRP20120018 T1 HR P20120018T1
- Authority
- HR
- Croatia
- Prior art keywords
- image
- group
- benzo
- dihydro
- lower alkyl
- Prior art date
Links
- -1 heterocycle sulfamide derivatives Chemical class 0.000 title claims abstract 9
- 239000004090 neuroprotective agent Substances 0.000 title 1
- 208000015122 neurodegenerative disease Diseases 0.000 claims abstract 8
- 208000014674 injury Diseases 0.000 claims abstract 6
- 230000001154 acute effect Effects 0.000 claims abstract 4
- 210000004556 brain Anatomy 0.000 claims abstract 4
- 230000001684 chronic effect Effects 0.000 claims abstract 4
- 230000016273 neuron death Effects 0.000 claims abstract 4
- 230000004112 neuroprotection Effects 0.000 claims abstract 4
- 210000000278 spinal cord Anatomy 0.000 claims abstract 4
- 230000008733 trauma Effects 0.000 claims abstract 4
- 208000027418 Wounds and injury Diseases 0.000 claims abstract 2
- 230000006378 damage Effects 0.000 claims abstract 2
- 125000000217 alkyl group Chemical group 0.000 claims 26
- 150000001875 compounds Chemical class 0.000 claims 18
- 150000003839 salts Chemical class 0.000 claims 17
- 229910052739 hydrogen Inorganic materials 0.000 claims 16
- 239000001257 hydrogen Substances 0.000 claims 16
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 15
- 125000004432 carbon atom Chemical group C* 0.000 claims 7
- 229910052736 halogen Inorganic materials 0.000 claims 6
- 150000002367 halogens Chemical class 0.000 claims 6
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 6
- KXSAIQPPGSSNKX-ZETCQYMHSA-N (2s)-6-chloro-2-[(sulfamoylamino)methyl]-2,3-dihydro-1,4-benzodioxine Chemical compound ClC1=CC=C2O[C@@H](CNS(=O)(=O)N)COC2=C1 KXSAIQPPGSSNKX-ZETCQYMHSA-N 0.000 claims 3
- 210000003128 head Anatomy 0.000 claims 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 3
- 230000003961 neuronal insult Effects 0.000 claims 3
- 230000002265 prevention Effects 0.000 claims 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 1
- 230000004693 neuron damage Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Neurology (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Toxicology (AREA)
- Biochemistry (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Psychiatry (AREA)
- Cardiology (AREA)
- Pain & Pain Management (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US75149405P | 2005-12-19 | 2005-12-19 | |
US11/612,146 US20070155823A1 (en) | 2005-12-19 | 2006-12-18 | Use of benzo-fused heterocycle sulfamide derivatives as neuroprotective agents |
PCT/US2006/048451 WO2007075698A2 (en) | 2005-12-19 | 2006-12-19 | Use of benzo-fused heterocycle sulfamide derivatives as neuroprotective agents |
Publications (1)
Publication Number | Publication Date |
---|---|
HRP20120018T1 true HRP20120018T1 (hr) | 2012-01-31 |
Family
ID=37951698
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HR20120018T HRP20120018T1 (hr) | 2005-12-19 | 2012-01-09 | Uporaba derivata benzo-kondenziranih heterocikličkih sulfamida kao neurozaštitnih sredstava |
Country Status (24)
Country | Link |
---|---|
US (1) | US20070155823A1 (pt) |
EP (1) | EP1968571B1 (pt) |
JP (1) | JP5190373B2 (pt) |
KR (1) | KR20080089405A (pt) |
AT (1) | ATE536182T1 (pt) |
AU (1) | AU2006331783A1 (pt) |
BR (1) | BRPI0620060A2 (pt) |
CA (1) | CA2634088A1 (pt) |
CR (1) | CR10171A (pt) |
CY (1) | CY1112444T1 (pt) |
DK (1) | DK1968571T3 (pt) |
EA (1) | EA016628B1 (pt) |
ES (1) | ES2375845T3 (pt) |
HK (1) | HK1124544A1 (pt) |
HR (1) | HRP20120018T1 (pt) |
IL (1) | IL192106A0 (pt) |
MY (1) | MY149175A (pt) |
NO (1) | NO20083033L (pt) |
NZ (1) | NZ569041A (pt) |
PL (1) | PL1968571T3 (pt) |
PT (1) | PT1968571E (pt) |
RS (1) | RS52220B (pt) |
SI (1) | SI1968571T1 (pt) |
WO (1) | WO2007075698A2 (pt) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MY147767A (en) | 2004-06-16 | 2013-01-31 | Janssen Pharmaceutica Nv | Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders |
KR20080012360A (ko) * | 2005-05-20 | 2008-02-11 | 얀센 파마슈티카 엔.브이. | 설파미드 유도체의 제조 방법 |
US8497298B2 (en) | 2005-12-19 | 2013-07-30 | Janssen Pharmaceutica Nv | Use of benzo-fused heterocycle sulfamide derivatives for lowering lipids and lowering blood glucose levels |
US8937096B2 (en) | 2005-12-19 | 2015-01-20 | Janssen Pharmaceutica Nv | Use of benzo-fused heterocyle sulfamide derivatives for the treatment of mania and bipolar disorder |
US8691867B2 (en) | 2005-12-19 | 2014-04-08 | Janssen Pharmaceutica Nv | Use of benzo-fused heterocycle sulfamide derivatives for the treatment of substance abuse and addiction |
TW200812573A (en) * | 2006-05-19 | 2008-03-16 | Janssen Pharmaceutica Nv | Co-therapy for the treatment of epilepsy and related disorders |
US20090247616A1 (en) * | 2008-03-26 | 2009-10-01 | Smith-Swintosky Virginia L | Use of benzo-fused heterocyle sulfamide derivatives for the treatment of anxiety |
US20090247617A1 (en) * | 2008-03-26 | 2009-10-01 | Abdel-Magid Ahmed F | Process for the preparation of benzo-fused heteroaryl sulfamates |
MX2010011498A (es) * | 2008-04-29 | 2010-11-12 | Nsab Af Neurosearch Sweden Ab | Moduladores de neurotransmision de dopamina. |
JP2011519839A (ja) * | 2008-04-29 | 2011-07-14 | エヌエスエイビー、フィリアル アヴ ノイロサーチ スウェーデン エービー、スヴェーリエ | ドーパミン神経伝達のモジュレーター |
WO2009133107A1 (en) * | 2008-04-29 | 2009-11-05 | Nsab, Filial Af Neurosearch Sweden Ab, Sverige | Modulators of dopamine neurotransmission |
US8809385B2 (en) | 2008-06-23 | 2014-08-19 | Janssen Pharmaceutica Nv | Crystalline form of (2S)-(-)-N-(6-chloro-2,3-dihydro-benzo[1,4]dioxin-2-ylmethyl)-sulfamide |
TWI406596B (zh) | 2008-06-30 | 2013-08-21 | Green Solution Tech Co Ltd | 發光二極體驅動電路、發光二極體驅動控制單元及其電晶體開關模組 |
US8815939B2 (en) * | 2008-07-22 | 2014-08-26 | Janssen Pharmaceutica Nv | Substituted sulfamide derivatives |
US8609849B1 (en) | 2010-11-30 | 2013-12-17 | Fox Chase Chemical Diversity Center, Inc. | Hydroxylated sulfamides exhibiting neuroprotective action and their method of use |
EP2760851A1 (en) | 2011-09-29 | 2014-08-06 | Janssen Pharmaceutica, N.V. | Process for the preparation of sulfamide derivatives |
JP2014528399A (ja) | 2011-09-29 | 2014-10-27 | ヤンセン ファーマシューティカ エヌ.ベー. | スルファミド誘導体の改善された調製プロセス |
NZ702974A (en) * | 2012-06-21 | 2016-03-31 | Eisai R&D Man Co Ltd | Novel indanesulfamide derivative |
EP3769759B1 (en) | 2018-03-20 | 2023-11-15 | Eisai R&D Management Co., Ltd. | Combination of an indanesulfamide derivative with perampanel for use in the treatment of epilepsy |
Family Cites Families (65)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2527861A (en) * | 1948-05-07 | 1950-10-31 | Monsanto Chemicals | Mono alkyl sulfamides |
BE636655A (pt) * | 1962-09-14 | |||
US3318952A (en) * | 1964-01-22 | 1967-05-09 | Sandoz Ag | Dibenzylsulfamides |
US3383414A (en) * | 1964-08-26 | 1968-05-14 | Sandoz Ag | Benzocycloalkyl sulfamides |
US3539573A (en) * | 1967-03-22 | 1970-11-10 | Jean Schmutz | 11-basic substituted dibenzodiazepines and dibenzothiazepines |
US3621096A (en) * | 1969-04-03 | 1971-11-16 | Univ North Carolina | Antidepressant method and composition for same comprising a tricyclic antidepressant and a thyroid hormone |
US5212326A (en) * | 1979-08-20 | 1993-05-18 | Abbott Laboratories | Sodium hydrogen divalproate oligomer |
FR2479825A1 (fr) * | 1980-04-04 | 1981-10-09 | Fabre Sa Pierre | Benzodioxanne 1,4 methoxy-2 propanolamines, leur preparation et leur application en tant que medicaments |
US4513006A (en) * | 1983-09-26 | 1985-04-23 | Mcneil Lab., Inc. | Anticonvulsant sulfamate derivatives |
US4804663A (en) * | 1985-03-27 | 1989-02-14 | Janssen Pharmaceutica N.V. | 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles |
IE58370B1 (en) * | 1985-04-10 | 1993-09-08 | Lundbeck & Co As H | Indole derivatives |
GB8607684D0 (en) * | 1986-03-27 | 1986-04-30 | Ici America Inc | Thiazepine compounds |
US4831031A (en) * | 1988-01-22 | 1989-05-16 | Pfizer Inc. | Aryl piperazinyl-(C2 or C4) alkylene heterocyclic compounds having neuroleptic activity |
US5158952A (en) * | 1988-11-07 | 1992-10-27 | Janssen Pharmaceutica N.V. | 3-[2-[4-(6-fluoro-1,2-benzisoxozol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9 tetrahydro-9-hydroxy-2-methyl-4H-pyrido [1,2-a]pyrimidin-4-one, compositions and method of use |
GB8908085D0 (en) * | 1989-04-11 | 1989-05-24 | Lundbeck & Co As H | New therapeutic use |
US5238945A (en) * | 1989-04-11 | 1993-08-24 | H. Lundbeck A/S | Method of treating psychoses |
US5194446A (en) * | 1989-06-12 | 1993-03-16 | A. H. Robins Company, Incorporated | Compounds having one or more aminosulfaonyloxy radicals useful as pharmaceuticals |
US5273993A (en) * | 1989-06-12 | 1993-12-28 | A. H. Robins Company, Incorporated | Compounds having one or more aminosulfonyloxy radicals useful as pharmaceuticals |
US5192785A (en) * | 1989-09-03 | 1993-03-09 | A. H. Robins Company, Incorporated | Sulfamates as antiglaucoma agents |
US5229382A (en) * | 1990-04-25 | 1993-07-20 | Lilly Industries Limited | 2-methyl-thieno-benzodiazepine |
IL103172A (en) * | 1991-09-19 | 1997-01-10 | Mcneilab Inc | Preparation of chlorosulfate and sulfamate derivatives of 2, 3:4, 5-bis-o-(1-methylethylidene)-beta-d-fructopyranose and (1-methylcyclohexyl) methanol |
US5242942A (en) * | 1992-04-28 | 1993-09-07 | Mcneilab, Inc. | Anticonvulsant fructopyranose cyclic sulfites and sulfates |
US5258402A (en) * | 1992-06-11 | 1993-11-02 | Mcneil-Ppc, Inc. | Imidate derivatives of pharmaceutically useful anticonvulsant sulfamates |
US5312925A (en) * | 1992-09-01 | 1994-05-17 | Pfizer Inc. | Monohydrate of 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)-ethyl)-6-chloro-1,3-dihydro-2H-indol-2-one-hydrochloride |
US5384327A (en) * | 1992-12-22 | 1995-01-24 | Mcneilab, Inc. | Anticonvulsant sorbopyranose sulfamates |
JPH11501619A (ja) * | 1995-02-15 | 1999-02-09 | ベアーズデン バイオ,インコーポレイテッド | アルキルカルボキシアミノ酸−カイネートレセプターのモジュレーター |
JP3235448B2 (ja) * | 1995-03-24 | 2001-12-04 | ダイソー株式会社 | 1,4−ベンゾジオキサン誘導体の製法 |
US5998380A (en) * | 1995-10-13 | 1999-12-07 | New England Medical Center Hospitals, Inc. | Treatment of migraine |
WO1997019682A1 (en) * | 1995-12-01 | 1997-06-05 | Synaptic Pharmaceutical Corporation | Aryl sulfonamide and sulfamide derivatives and uses thereof |
US5753693A (en) * | 1996-06-28 | 1998-05-19 | Ortho Pharmaceutical Corporation | Anticonvulsant derivatives useful in treating manic-depressive bipolar disorder |
CA2258893C (en) * | 1996-06-28 | 2005-06-14 | Ortho-Mcneil Pharmaceutical, Inc. | Anticonvulsant sulfamate derivatives useful in treating obesity |
US5753694A (en) * | 1996-06-28 | 1998-05-19 | Ortho Pharmaceutical Corporation | Anticonvulsant derivatives useful in treating amyotrophic lateral sclerosis (ALS) |
ATE293458T1 (de) * | 1996-08-23 | 2005-05-15 | Algos Pharm Corp | Antikonvulsive mitteln enthaltende zubereitung zur behandlung von neuropathischen schmerzen |
US20020015713A1 (en) * | 1996-10-24 | 2002-02-07 | Murdock Robert W. | Methods and transdermal compositions for pain relief |
US5760007A (en) * | 1997-07-16 | 1998-06-02 | Ortho Pharmaceutical Corporation | Anticonvulsant derivatives useful in treating neuropathic pain |
US5935933A (en) * | 1997-07-16 | 1999-08-10 | Ortho-Mcneil Pharmaceutical, Inc. | Anticonvulsant derivatives useful in treating neuropathic pain |
ATE279919T1 (de) * | 1997-08-15 | 2004-11-15 | Carolyn Ann Fairbanks | Agmatin für die behandlung neuropathischer schmerzen |
IL144406A0 (en) * | 1999-01-19 | 2002-05-23 | Ortho Mcneil Pharm Inc | Anticonvulsant derivatives useful in treating cluster headaches |
AU779248B2 (en) * | 1999-02-24 | 2005-01-13 | University Of Cincinnati, The | Use of sulfamate derivatives for treating impulse control disorders |
WO2000061138A1 (en) * | 1999-04-08 | 2000-10-19 | Ortho-Mcneil Pharmaceutical, Inc. | Anticonvulsant derivatives useful in treating chronic neurodegenerative disorders |
JP2002541199A (ja) * | 1999-04-08 | 2002-12-03 | オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド | 脂質を下げることに有用な抗痙攣薬誘導体 |
EP1210118B1 (en) * | 1999-08-20 | 2004-12-08 | Ortho-McNeil Pharmaceutical, Inc. | Composition comprising a tramadol material and an anticonvulsant drug |
US6322503B1 (en) * | 2000-02-17 | 2001-11-27 | G. Roger Sparhawk, Jr. | Method of diagnosing, tracking, and treating depression |
CA2415093A1 (en) * | 2000-07-07 | 2002-01-17 | Carlos Plata-Salaman | Anticonvulsant derivatives useful for preventing the development of type ii diabetes mellitus and syndrome x |
US6627653B2 (en) * | 2000-08-02 | 2003-09-30 | Ortho-Mcneil Pharmaceutical, Inc. | Anticonvulsant derivatives useful for the treatment of depression |
US7256184B2 (en) * | 2000-10-16 | 2007-08-14 | Rodriguez Victorio C | Treatment of aging disorders in humans |
WO2002060388A2 (en) * | 2001-01-30 | 2002-08-08 | Merck & Co., Inc. | Acyl sulfamides for treatment of obesity, diabetes and lipid disorders |
US20030100594A1 (en) * | 2001-08-10 | 2003-05-29 | Pharmacia Corporation | Carbonic anhydrase inhibitor |
US6559293B1 (en) * | 2002-02-15 | 2003-05-06 | Transform Pharmaceuticals, Inc. | Topiramate sodium trihydrate |
US8637512B2 (en) * | 2002-07-29 | 2014-01-28 | Glaxo Group Limited | Formulations and method of treatment |
US6949518B1 (en) * | 2003-06-25 | 2005-09-27 | Pao-Hsien Chu | Methods for treating macular degeneration with topiramate |
CN1897950A (zh) * | 2003-10-14 | 2007-01-17 | 惠氏公司 | 稠合芳基和杂芳基衍生物及其使用方法 |
TW200612905A (en) * | 2004-06-16 | 2006-05-01 | Janssen Pharmaceutica Nv | Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders |
US20060276528A1 (en) * | 2004-08-24 | 2006-12-07 | Abdel-Magid Ahmed F | Novel benzo-fused heteroaryl sulfamide derivatives useful as anticonvulsant agents |
MY142329A (en) * | 2004-08-24 | 2010-11-15 | Janssen Pharmaceutica Nv | Novel benzo-fused heteroaryl sulfamide derivatives useful as anticonvulsant agents. |
CN101218223A (zh) * | 2005-04-22 | 2008-07-09 | 惠氏公司 | 苯并二烷和苯并二氧戊环衍生物及其应用 |
KR20080012360A (ko) * | 2005-05-20 | 2008-02-11 | 얀센 파마슈티카 엔.브이. | 설파미드 유도체의 제조 방법 |
US20070155824A1 (en) * | 2005-12-19 | 2007-07-05 | Smith-Swintosky Virginia L | Use of benzo-fused heterocycle sulfamide derivatives for disease modification / epileptogenesis |
TW200812573A (en) * | 2006-05-19 | 2008-03-16 | Janssen Pharmaceutica Nv | Co-therapy for the treatment of epilepsy and related disorders |
US20070293476A1 (en) * | 2006-05-19 | 2007-12-20 | Smith-Swintosky Virginia L | Co-therapy for the treatment of epilepsy and related disorders |
MX2010007490A (es) * | 2008-01-07 | 2010-08-17 | Janssen Pharmaceutica Nv | Preparacion de derivados de sulfamida. |
US20090247618A1 (en) * | 2008-03-26 | 2009-10-01 | Ballentine Scott A | Process for preparation of benzo-fused heteroaryl derivatives |
US20090247617A1 (en) * | 2008-03-26 | 2009-10-01 | Abdel-Magid Ahmed F | Process for the preparation of benzo-fused heteroaryl sulfamates |
US8809385B2 (en) * | 2008-06-23 | 2014-08-19 | Janssen Pharmaceutica Nv | Crystalline form of (2S)-(-)-N-(6-chloro-2,3-dihydro-benzo[1,4]dioxin-2-ylmethyl)-sulfamide |
US8815939B2 (en) * | 2008-07-22 | 2014-08-26 | Janssen Pharmaceutica Nv | Substituted sulfamide derivatives |
-
2006
- 2006-12-18 US US11/612,146 patent/US20070155823A1/en not_active Abandoned
- 2006-12-19 BR BRPI0620060-5A patent/BRPI0620060A2/pt not_active IP Right Cessation
- 2006-12-19 PL PL06845823T patent/PL1968571T3/pl unknown
- 2006-12-19 RS RS20120057A patent/RS52220B/en unknown
- 2006-12-19 EA EA200870087A patent/EA016628B1/ru not_active IP Right Cessation
- 2006-12-19 KR KR1020087017501A patent/KR20080089405A/ko not_active Application Discontinuation
- 2006-12-19 AU AU2006331783A patent/AU2006331783A1/en not_active Abandoned
- 2006-12-19 WO PCT/US2006/048451 patent/WO2007075698A2/en active Application Filing
- 2006-12-19 SI SI200631254T patent/SI1968571T1/sl unknown
- 2006-12-19 NZ NZ569041A patent/NZ569041A/en not_active IP Right Cessation
- 2006-12-19 AT AT06845823T patent/ATE536182T1/de active
- 2006-12-19 JP JP2008547445A patent/JP5190373B2/ja not_active Expired - Fee Related
- 2006-12-19 CA CA002634088A patent/CA2634088A1/en not_active Abandoned
- 2006-12-19 MY MYPI20082184A patent/MY149175A/en unknown
- 2006-12-19 DK DK06845823.1T patent/DK1968571T3/da active
- 2006-12-19 EP EP06845823A patent/EP1968571B1/en active Active
- 2006-12-19 ES ES06845823T patent/ES2375845T3/es active Active
- 2006-12-19 PT PT06845823T patent/PT1968571E/pt unknown
-
2008
- 2008-06-12 IL IL192106A patent/IL192106A0/en unknown
- 2008-07-04 NO NO20083033A patent/NO20083033L/no not_active Application Discontinuation
- 2008-07-21 CR CR10171A patent/CR10171A/es not_active Application Discontinuation
-
2009
- 2009-03-17 HK HK09102533.1A patent/HK1124544A1/xx not_active IP Right Cessation
-
2012
- 2012-01-09 HR HR20120018T patent/HRP20120018T1/hr unknown
- 2012-02-23 CY CY20121100189T patent/CY1112444T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
EA016628B1 (ru) | 2012-06-29 |
PT1968571E (pt) | 2012-02-01 |
AU2006331783A1 (en) | 2007-07-05 |
MY149175A (en) | 2013-07-31 |
EA200870087A1 (ru) | 2009-12-30 |
CR10171A (es) | 2009-01-16 |
ATE536182T1 (de) | 2011-12-15 |
JP5190373B2 (ja) | 2013-04-24 |
NO20083033L (no) | 2008-09-16 |
RS52220B (en) | 2012-10-31 |
IL192106A0 (en) | 2009-08-03 |
BRPI0620060A2 (pt) | 2011-11-01 |
EP1968571A2 (en) | 2008-09-17 |
US20070155823A1 (en) | 2007-07-05 |
WO2007075698A3 (en) | 2007-08-16 |
PL1968571T3 (pl) | 2012-04-30 |
NZ569041A (en) | 2011-04-29 |
HK1124544A1 (en) | 2009-07-17 |
WO2007075698A2 (en) | 2007-07-05 |
SI1968571T1 (sl) | 2012-03-30 |
CA2634088A1 (en) | 2007-07-05 |
EP1968571B1 (en) | 2011-12-07 |
ES2375845T3 (es) | 2012-03-06 |
DK1968571T3 (da) | 2012-02-27 |
CY1112444T1 (el) | 2015-12-09 |
JP2009520031A (ja) | 2009-05-21 |
KR20080089405A (ko) | 2008-10-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HRP20120018T1 (hr) | Uporaba derivata benzo-kondenziranih heterocikličkih sulfamida kao neurozaštitnih sredstava | |
HRP20110384T1 (hr) | Uporaba derivata benzo-kondenziranih heterocikličkih sulfamida za liječenje manije i bipolarnog poremećaja | |
HRP20110726T2 (hr) | Uporaba derivata benzo-kondenziranih heterocikliäśkih sulfamida za lijeäśenje pretilosti | |
HRP20100007T1 (hr) | Upotreba benzo-spojenih heterocikličkih derivata sulfamida za liječenje boli | |
HRP20110008T1 (hr) | Uporaba derivata benzo-kondenziranih heterocikličkih sulfamida za smanjenje razine masnoća i šećera u krvi | |
JP2009520031A5 (pt) | ||
PE20080716A1 (es) | Coterapia constituida por un derivado de heterociclosulfamida benzofusionado y uno o varios agentes anticonvulsivantes y/o antilepticos | |
JP2009520030A5 (pt) | ||
JP2009520036A5 (pt) | ||
AR064561A1 (es) | Derivados de 2-aza-biciclo[3.1.0]hexano y su uso en la preparacion de un medicamento para el tratamiento de enfermedades relacionadas con disfunciones generales del sistema de la orexina. | |
ES2573844T3 (es) | Derivados de sulfamidas y sulfamatos para el tratamiento de epilepsia y trastornos relacionados | |
CO7250451A2 (es) | Formulación oftálmica y método para mitigar la presbicia | |
AR076040A1 (es) | Composicion que comprende al menos un compuesto flavonoide, con la condicion de que el compuesto flavonoide no sea hesperetina, y hesperetina | |
TW200716595A (en) | Chromane and chromene derivatives and uses thereof | |
BR9913157A (pt) | Processos para tratar ou previnir infecção causada por pelo menos um vìrus das flaviviridae e doenças associadas com a referida infecção e infecção causada por pelo menos um vìrus do gênero hepacivìrus da flaviviridade e doenças associadas com a referida infecção, composição farmacêutica para tratar ou previnir infecções virais, e, composto | |
RU2007133167A (ru) | Препарат на основе смеси флавоноидов со свободным в-циклом и флаванов, как терапевтический агент | |
UY27875A1 (es) | Prodrogas 2 ' y 3 ' de nucleósidos modificados para tratar flaviviridae | |
CR8349A (es) | Derivados de dihidrobenzofuranilo alcanamina y metodos para su uso | |
BRPI0520752A2 (pt) | produto absorvente | |
KR890017248A (ko) | 종양억제제인 방향족 및 헤테로사이클릭 카복스아미드 유도체 | |
WO2009111603A2 (en) | Deitary supplement for eye health | |
KR950702970A (ko) | 사람 면역결필 바이러스(HIV) 역전사효소의 억제제로서의 벤족사지논(Benzoxazinones as inhibitors of HIV reverse transcriptase) | |
WO2008052256A1 (en) | Prevention and reversal of chemotherapy-induced peripheral neuropathy | |
MX2010004312A (es) | Derivados de 1,3,4-tiadiazol espiro-condensados para inhibir la actividad de quinesina de la proteina de quinesina del huso. | |
DE60111964D1 (de) | Nahrungsergänzungsmittel auf Basis von schwarzem Johannisbeeröl |